Publication: No current evidence for widespread dosage compensation in S. cerevisiae
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
eLife Sciences Publications, Ltd
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Torres, Eduardo M, Michael Springer, and Angelika Amon. 2016. “No current evidence for widespread dosage compensation in S. cerevisiae.” eLife 5 (1): e10996. doi:10.7554/eLife.10996. http://dx.doi.org/10.7554/eLife.10996.
Research Data
Abstract
Previous studies of laboratory strains of budding yeast had shown that when gene copy number is altered experimentally, RNA levels generally scale accordingly. This is true when the copy number of individual genes or entire chromosomes is altered. In a recent study, Hose et al. (2015) reported that this tight correlation between gene copy number and RNA levels is not observed in recently isolated wild Saccharomyces cerevisiae variants. To understand the origins of this proposed difference in gene expression regulation between natural variants and laboratory strains of S. cerevisiae, we evaluated the karyotype and gene expression studies performed by Hose et al. on wild S. cerevisiae strains. In contrast to the results of Hose et al., our reexamination of their data revealed a tight correlation between gene copy number and gene expression. We conclude that widespread dosage compensation occurs neither in laboratory strains nor in natural variants of S. cerevisiae. DOI: http://dx.doi.org/10.7554/eLife.10996.001
Description
Other Available Sources
Keywords
dosage compensation, aneuploidy, gene expression,
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service